Login to Your Account



Bench Press: BioWorld Looks at Translational Medicine


Monday, April 8, 2013
Researchers from Stanford University published new evidence to support the surprising notion that amyloid fibrils, best known as the likely culprits in Alzheimer's disease, can be beneficial in multiple sclerosis and other neuroinflammatory diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription